Cancer drug can rebalance kidney function in a devastating genetic disease

(Wellcome Trust/ Cancer Research UK Gurdon Institute) Researchers at the University of Cambridge and the University of Zurich have discovered that a drug newly approved for cancer improves kidney dysfunction in a mouse model of Dent disease 2 and Lowe syndrome